Lincoln Pharmaceuticals Limited at its Annual General Meeting held on September 29, 2023 declared dividend at INR 1.50 per equity share for the financial year 2022-23....
Lincoln Pharmaceuticals records a significant increase in net profit for Q4 and FY23, along with a dividend recommendation, as it continues manufacturing therapeutic products.
Nandish Shah of HDFC Securities believes that short-term trend of the Nifty is weak. Therefore, his advice is to remain cautious till the Nifty closes above the 17,250 levels.
Nagaraj Shetti of HDFC Securities feels a sustainable move above the immediate resistance of 17,800 could open strong upside bounce towards 18,000 mark.
The company has also acquired a facility in Mehsana for this, and expects the commercial operations from the plant to start from March 2022, Lincoln Pharmaceutical said in a regulatory filing.